In this Huffington Post blog, FHI 360’s Ward Cates and Laneta Dorflinger join with the Gates Foundation’s Kirsten Vogelsong to discuss the importance of developing new low-cost, long-acting contraceptives that meet the needs of the world’s poorest women.
